Author:
Burel Sebastien A.,Hart Christopher E.,Cauntay Patrick,Hsiao Jill,Machemer Todd,Katz Melanie,Watt Andy,Bui Huynh-hoa,Younis Husam,Sabripour Mahyar,Freier Susan M.,Hung Gene,Dan Amy,Prakash T.P.,Seth Punit P.,Swayze Eric E.,Bennett C. Frank,Crooke Stanley T.,Henry Scott P.
Publisher
Oxford University Press (OUP)
Reference58 articles.
1. The clinical experience of antisense therapy to ICAM-1 in Crohn's disease;Yacyshyn;Curr. Opin. Mol. Ther.,1999
2. Pharmacological Properties of 2'-O-Methoxyethyl-Modified Oligonucleotides
3. Evaluation of 2′ modified oligonucleotides containing deoxy gaps as antisense inhibitors of gene expression;Monia;J. Biol. Chem.,1993
4. Antisense Drug Technology
5. RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
Cited by
134 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献